Stock Screener App

Frei -

Installieren

Medical Instruments & Supplies

14.49

1.56% -0.23

Pulse Biosciences Inc (PLSE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten

How buybacks impact Pulse Biosciences Inc. stock valueEarnings Recap Summary & Free Verified High Yield Trade Plans - ulpravda.ru

Will Pulse Biosciences Inc. (6L8) stock profit from automation wave2025 Key Highlights & Entry Point Confirmation Signals - ulpravda.ru

Pulse Biosciences appoints healthcare veteran Maria Sainz to board By Investing.com - Investing.com Nigeria

Pulse Biosciences Adds Veteran Healthtech Leader to Board - TipRanks

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - BioSpace

Weekly Earnings: Will Pulse Biosciences Inc. (6L8) stock outperform value peersEarnings Overview Summary & Growth Focused Entry Reports - ulpravda.ru

Will Pulse Biosciences Inc. stock reach Wall Street targetsMarket Trend Review & Real-Time Volume Trigger Notifications - ulpravda.ru

Is MBX Biosciences Inc. stock positioned well for digital economyJuly 2025 Short Interest & Safe Entry Momentum Tips - ulpravda.ru

Why Pulse Biosciences Inc. stock remains resilient2025 Key Lessons & Daily Stock Momentum Reports - ulpravda.ru

Can Pulse Biosciences Inc. (6L8) stock deliver double digit returnsMarket Weekly Review & Safe Capital Allocation Plans - ulpravda.ru

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium - Bluefield Daily Telegraph

(PLSE) Volatility Zones as Tactical Triggers - Stock Traders Daily

What analysts say about Pulse Biosciences Inc 6L8 stockEarnings Growth Projections & Test Our Stock Screener — Free Forever - Early Times

Chipmakers Recap: How Pulse Biosciences Inc 6L8 stock responds to bond market - moha.gov.vn

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Bluefield Daily Telegraph

Total debt per share of Pulse Biosciences, Inc. – MUN:6L8 - TradingView — Track All Markets

Positron (OTCMKTS:POSC) vs. Pulse Biosciences (NASDAQ:PLSE) Critical Comparison - Defense World

What drives Pulse Biosciences Inc 6L8 stock priceHigh Dividend Yield Stocks & High Profit Market Growth - earlytimes.in

MSN Money - MSN

Understanding the Setup: (PLSE) and Scalable Risk - Stock Traders Daily

Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial - Sahm

Pulse Biosciences Updates Investors on Product Advancements - MSN

Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring A 44.74% Potential Upside - DirectorsTalk Interviews

Why Pulse Biosciences (PLSE) Is Up 8.0% After FDA Clears Pivotal Atrial Fibrillation Trial - Sahm

Pulse Biosciences holds 2025 annual stockholder meeting - MSN

Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - Sahm

Can Pulse Biosciences Inc. stock beat market expectations this quarterEarnings Recap Report & Growth Focused Stock Reports - Улправда

Forecast Cut: Will Pulse Biosciences Inc. stock outperform tech sector in 2025July 2025 EndofMonth & Weekly Return Optimization Plans - Улправда

What technical signals suggest for Pulse Biosciences Inc. stockSell Signal & AI Driven Price Forecasts - Улправда

Pulse Biosciences announces inducement grants under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Market Pulse: How Aura Biosciences Inc. stock performs in high volatility marketsWall Street Watch & Long-Term Safe Investment Ideas - Улправда

Aug Fed Impact: Can Pulse Biosciences Inc. (6L8) stock deliver double digit returnsQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - Улправда

PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial - sharewise.com

How Pulse Biosciences Inc. stock responds to policy changesMarket Risk Summary & Daily Risk Controlled Trade Plans - DonanımHaber

Can Pulse Biosciences Inc. stock resist market sell offs2025 Support & Resistance & Community Verified Trade Signals - DonanımHaber

FDA approves Pulse Biosciences’ atrial fibrillation trial By Investing.com - Investing.com Australia

How Pulse Biosciences Inc. stock benefits from tech adoptionMarket Sentiment Report & Consistent Profit Trading Strategies - DonanımHaber

Short Covering: Can Pulse Biosciences Inc. stock beat market expectations this quarter2025 Top Decliners & Long-Term Growth Plans - Улправда

Pulse Biosciences wins FDA approval to begin PFA catheter study - MedTech Dive

Pulse Biosciences gains FDA IDE for NANOPULSE-AF trial - TipRanks

Pulse Biosciences IDE Approval for Atrial Fibrillation Study - TradingView — Track All Markets

[8-K] PULSE BIOSCIENCES, INC. Reports Material Event | PLSE SEC FilingForm 8-K - Stock Titan

Pulse Biosciences Receives FDA Approval to Launch Cardiac Catheter Ablation Study - marketscreener.com

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation - Investing News Network

FDA approves Pulse Biosciences’ atrial fibrillation trial - Investing.com

Pulse Biosciences announces FDA IDE approval to initiate its nPulse cardiac catheter ablation system study - marketscreener.com

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study - TradingView — Track All Markets

Will Pulse Biosciences Inc. stock outperform tech sector in 2025Market Performance Recap & Scalable Portfolio Growth Ideas - Улправда

ALGN

$172.79

1.30%

SOLV

$86.14

0.43%

COO

$83.45

0.38%

HOLX

$74.87

0.01%

WST

$275.52

0.11%

MDLN

$40.52

1.77%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters